Bethanechol pediatric dose calculator
Use this Bethanechol pediatric dose calculator to match the prescribed child dose to the exact liquid, tablet, or capsule strength before you give it.
dose calculator basics
Bethanechol pediatric dose calculator details
Use this Bethanechol calculator as the fast parent page for weight-based dose checks, mL conversion, common strengths, and the practical safety steps that generic calculator sites often skip.
Formula
mL per dose = (child weight in kg x prescribed mg/kg/day / doses per day) / medication concentration in mg per mL.
Worked example
For a 20 kg child using 0.3 mg/kg/day divided 3 times daily with 1 mg/1 mL, calculate the daily mg target, divide by the schedule, then convert that mg amount into mL for the selected product.
Safety checks before using the result
- Use the exact product strength in hand before measuring the dose.
- Confirm maximum dose, age limits, and indication-specific cautions when they apply.
- Escalate urgent symptoms or medication reactions instead of repeating doses from calculator output alone.
Practical dosing guide
Before you measure the dose
Use this page to match the prescribed Bethanechol plan to the exact liquid or tablet strength and the follow-up checks that matter most.
- What it is usually used for
- Bethanechol is a cholinergic agonist used to improve bladder emptying in children with non-obstructive urinary retention.
- Common forms
- Common forms include 1 mg/mL compounded suspension, 5 mg/mL compounded suspension, and 10 mg tablet.
- How the schedule is usually written
- Pediatric use is off-label and specialist-directed: typically 0.1–0.2 mg/kg per dose three to four times daily, max 10 mg per dose.
Bethanechol pediatric medication summary
Bethanechol is a cholinergic agonist used to improve bladder emptying in children with non-obstructive urinary retention.
Always rule out mechanical obstruction (posterior urethral valves, ureterocele) before prescribing—bethanechol cannot overcome outlet blockage and may worsen hydronephrosis.
Start low (0.1–0.2 mg/kg/dose) and titrate every 1–2 weeks while tracking post-void residuals, wetting episodes, and cholinergic side effects.
Bethanechol indications and common pediatric uses
Bethanechol is best viewed as a selective adjunct, not a routine first-line pediatric bladder medication. It is considered when detrusor hypocontractility is documented and core bladder-program steps are already in place.
Neurogenic bladder with detrusor areflexia or hypocontractility
Neurogenic bladder with detrusor areflexia or hypocontractility: Adjunct to clean intermittent catheterization when residuals remain high despite optimized schedules, with goals centered on safer emptying and renal-pressure protection.
Postoperative or postpartum non-obstructive urinary retention
Postoperative or postpartum non-obstructive urinary retention: Use only after confirming non-obstructive retention; combine with timed voiding and pelvic floor relaxation, then discontinue once spontaneous voiding stabilizes.
Spinal cord injury bladder rehabilitation (subacute phase)
Spinal cord injury bladder rehabilitation (subacute phase): Adjunct to CIC and bladder training during rehab; stop if detrusor pressures become unsafe or dysreflexia events rise.
Autonomic neuropathy bladder hypomotility (e.g., diabetes or chemotherapy)
Autonomic neuropathy bladder hypomotility (e.g., diabetes or chemotherapy): Trial only after behavioral strategies, CIC, and other bladder-program options fail to restore emptying; coordinate with endocrine/oncology teams.
Severe colonic inertia under pediatric motility specialist guidance
Severe colonic inertia under pediatric motility specialist guidance: Use low doses only in specialist-directed plans that already include bowel regimen, pelvic floor therapy, and nutrition support.
Postpartum urinary retention in young adults
Postpartum urinary retention in young adults: Use short courses with bladder scanning and timed voiding; discontinue when residuals improve or cholinergic symptoms limit tolerance.
How to give Bethanechol
- Bethanechol dosing should be individualized and linked to a structured bladder program rather than prescribed as a stand-alone intervention.
- Give tablets about 30 minutes before meals with water when feasible. For compounded suspensions (1 mg/mL and 5 mg/mL both exist, so check the mg/mL on the label), shake well, dose with an oral syringe, and follow pharmacy beyond-use dating.
- Use a daily log (catheter volumes, voided amounts, accidents, side effects) to guide titration decisions. Give families a clear hold-and-call action plan for wheezing, marked secretions, bradycardia symptoms, or persistent abdominal pain/diarrhea.
Bethanechol side effects, contraindications, and interactions
Bethanechol side effects are mostly cholinergic and usually dose-related. Families should know what is expected (mild cramping, sweating, drooling) and what is urgent (wheezing, fainting, very slow pulse).
Common side effects
- Use a simple symptom log during titration so bowel pattern, appetite, breathing symptoms, and dizziness trends are easy to review at follow-up.
- If diarrhea, cramping, sweating, or drooling become frequent, contact the prescribing team before the next dose change.
- Hold bethanechol and seek urgent care for wheezing, breathing effort, fainting, persistent vomiting, or marked lethargy.
Safety checks
- Mechanical urinary obstruction (posterior urethral valves, severe urethral stricture)
- Suspected or confirmed gastrointestinal obstruction or inflammatory bowel flare
- Uncontrolled asthma or history of medication-induced bronchospasm
- Bradyarrhythmias or AV conduction defects without pacing support
- Known hypersensitivity to bethanechol/choline esters
- Peptic ulcer disease or severe gastroesophageal reflux
Drug interactions
- Review the full medication list with a clinician or pharmacist before combining therapies.
Bethanechol mechanism and clinical pearls
Bethanechol is a direct muscarinic agonist that primarily affects peripheral smooth muscle, especially the bladder detrusor. M3 activation drives contraction, while M2 signaling supports coordinated emptying dynamics. In selected children with non-obstructive retention, this can improve bladder emptying when integrated into structured catheter or timed-voiding plans. Because bethanechol is a quaternary ammonium compound, CNS penetration is minimal and most adverse effects are peripheral, including GI cramping, diarrhea, sweating, salivation, bradycardia, and bronchospasm. Clinical effectiveness depends on practical execution: reliable interval dosing, symptom tracking, and quick response when cholinergic intolerance appears.
Obtain uroflow/EMG or catheterization residuals showing hypocontractility; bethanechol adds little when obstruction or overactivity is the primary issue.
Schedule each dose 30–60 minutes before CIC or coached voiding; this synchrony improves patient feedback and diary accuracy.
Any new bronchospasm, sweating, or abdominal pain warrants holding doses and calling the team—families need explicit stop rules.
Frequently asked questions about Bethanechol
Food slows absorption and can increase nausea. Giving the medicine one hour before or two hours after meals helps it reach the bladder quickly while reducing stomach upset.
Hold the next dose, document the symptoms, and call the care team. These are early signs of cholinergic side effects. If the child also has trouble breathing, severe vomiting, or feels faint, seek emergency care.
Sometimes. Urologists may alternate the timing of each medicine to balance bladder emptying and capacity. Never start or stop an anticholinergic without confirming the plan, because the medicines can counteract each other.
It depends on bladder goals. Many programs reassess every few months. If bladder emptying improves and residual volumes stay low, the team may taper the dose or stop the medicine altogether.
Give it when you remember unless the next dose is less than four hours away. If it is close to the next scheduled time, skip the missed dose—do not double up. Keep logging voiding data so the care team can see how the interruption affected bladder emptying.
It increases gut motility, but side effects often outweigh benefits in those situations. Only use for GI issues if a specialist recommends it, and monitor for diarrhea or abdominal pain closely.
Yes, but monitor hydration and watch for dizziness or wheezing during exertion. Inform coaches about the medication and carry the emergency plan, especially for children with a history of asthma.
Sources reviewed for Bethanechol
aua-neurogenic-lutd
statpearls-neurogenic-bladder
dailymed-bethanechol
statpearls-bethanechol
stanford-sci-urology
Bethanechol Chloride Tablets — Prescribing Information
U.S. National Library of Medicine
Source